(PubMed) Dorant E, van den Brandt PA, Goldbohm RA
In our research, we have asked more than 7,500 individuals in the United States, Australia, India, Israel, and the United Kingdom to consider various configurations of future U.S
J Int Neuropsychol Soc
Nervous system disorders Uncommon: Headache Not known: Convulsions*, Dizziness Heart disease Not known: Palpitations Vascular pathologies Uncommon: Hypertension, Hypotension Respiratory, thoracic and mediastinal pathologies Not known: Dyspnea Gastrointestinal disorders Common: Vomiting, Nausea, Diarrhea, Abdominal pain Uncommon: Dysgeusia, Dyspepsia, Dry mouth Skin and subcutaneous tissue disorders Uncommon: Abnormal skin odor ** Not known: Itching, Skin rash Musculoskeletal and connective tissue disorders Uncommon: Muscle spasms Not known: Myasthenia***, Muscle tension Systemic disorders and conditions related to the administration site Uncommon: Chest pain, Feeling abnormal, Pyrexia, Injection site reaction**** Diagnostic tests Uncommon: Increased blood pressure Very rare: Increased INR*****
It is advisable to talk to a healthcare professional before starting any ipamorelin regimen to assess its suitability for your individual health needs
2020 Jan;151:104554